Regulators from the U.S. Food and Drug Administration (FDA) say that ads for the acne drug Aczone "grossly overstates" the drug's effectiveness. The FDA has warned drugmaker Allergan that the medical journal ad left out risk information, and mislead readers into assuming the drug was safer than has been demonstrated. The drugmaker says that the ad in question is no longer running.
Read moreIn October of 2010, Botox (onabotulinumtoxinA) was approved by the FDA for the treatment of chronic Migraine. This prompted many... Read more »
Chronic Migraine can be a severely debilitating disease. The impact on the lives of Migraineurs can be devastating. The burden of Chronic... Read more »
Several herbs, either taken alone or in combination, can prove helpful in treating mild insomnia. Valerian, one well-known remedy, is... Read more »
A couple of months ago a supplement company that I do some writing for sent me a bottle of Therapain Plus® to try because they wanted me... Read more »
For all the bisphosphonate medication patients out there, the FDA has just approved a new dosage of Fosamax that contains 70 mg of... Read more »
According to new research, combining the clot-preventing drug Plavix with aspirin is an effective substitute treatment for people at high risk of... Read more »
According to one expert, people who suffer from migraines and high blood pressure could be more likely to suffer a stroke than those who only have... Read more »
A new study suggests that combining medication with behavioral therapy may help ease incontinence. Researchers studied 416 adults with overactive... Read more »
A new study may reignite the debate on the risks posed by hormone replacement therapy (HRT) on breast cancer. New findings from the American... Read more »
A combination of an imaging test with memory recall test appears to be the best predictor of Alzheimer's disease. For the study, researchers... Read more »